Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s11060-010-0520-2, but it redirected us to https://link.springer.com/article/10.1007/s11060-010-0520-2. The analysis below is for the second page.

Title[redir]:
Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas | Journal of Neuro-Oncology
Description:
The role of epigenetics and significance of aberrant gene regulation in etiology of cancer is a well-established phenomenon. The hallmark of cancer epigenetics is aberrant DNA methylation consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes (TSGs) by DNA methyltransferases (DNMTs). In mammals, DNA methylation is catalyzed by DNMTs encoded by DNMT1, DNMT3A, and DNMT3B. Interestingly, little is known about variation in the methylation status of epigenetic regulators themselves in gliomas. Here, we report significant overexpression of DNMT1 and DNMT3B. A study of the methylation status and histone modifications at the promoter region of DNA methyltransferase I (DNMT1) gene revealed an unmethylated DNA promoter, similar to that detected in normal brain tissues. However, a differential histone code with distinct euchromatin marks—AcH3, AcH4, and H3k4me2—was specifically detected in tumors, unlike in normal brain tissues, which were found predominantly enriched with heterochromatin marks such as H3K9me2 and H3K27me3. In contrast, a differential methylation pattern of DNMT3B gene promoter occurred in glioma tumors, wherein it was found hypomethylated. Transcriptional silencing by CpG island methylation is a prevalent mechanism for inactivation of TSGs. Inhibiting DNMTs by 5-azacytidine (DNMT inhibitor) treatment led to significant inhibition of expression of DNMT1 and DNMT3B and enhanced expression of TSGs such as PTEN and p21 analyzed in this study. Our studies have identified effects of increased presence of DNMTs on inhibition of tumor suppressors that are epigenetically silenced in gliomas, thereby leading to aberrant regulation of cell cycle progression and failure to maintain genomic stability.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, cancer, dna, methylation, human, res, dnmt, expression, cell, dnmtb, tumor, gene, genes, histone, methyltransferases, gliomas, methyltransferase, cells, baylin, promoter, content, epigenetic, dnmts, brain, stem, privacy, cookies, journal, regulation, shiras, hypermethylation, suppressor, dnmta, tumors, cpg, access, biol, novo, herman, india, analysis, data, information, publish, research, search,

Topics {✒️}

s1 q-rt-pcr expression month download article/chapter s2 qrt-pcr analyses covalent histone modifications—miswritten multiple tumor-related genes c-met autocrine activation peri-centromeric satellite regions tumor suppressor genes distinct euchromatin marks—ach3 tumor suppressor micrornas histone acetylation patterns polycomb target genes full article pdf human gapdh controls faint pcr product neuro-oncology aims neural stem cells de novo methylation privacy choices/manage cookies cancer stem cells anjali shiras dna methylation machinery dna methylation errors stepwise dna methylation abnormal dna methylation human cell lines hemimethylated target sites chip data cell cycle progression cancer cell survival electronic supplementary material aberrant gene regulation papillary glioneuronal tumor unmethylated dna promoter differential methylation pattern concordant methylation behaviours cpg island methylation nih 3t3 cells differential histone code san miguel jf hamilton sr acetylated histone h3 histone h3 lysine 4 entamoeba histolytica dna human dna methyltransferases human cancer cells poorer tumor differentiation histone modifications high-grade gliomas trna methyltransferase dnmt2

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas
         description:The role of epigenetics and significance of aberrant gene regulation in etiology of cancer is a well-established phenomenon. The hallmark of cancer epigenetics is aberrant DNA methylation consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes (TSGs) by DNA methyltransferases (DNMTs). In mammals, DNA methylation is catalyzed by DNMTs encoded by DNMT1, DNMT3A, and DNMT3B. Interestingly, little is known about variation in the methylation status of epigenetic regulators themselves in gliomas. Here, we report significant overexpression of DNMT1 and DNMT3B. A study of the methylation status and histone modifications at the promoter region of DNA methyltransferase I (DNMT1) gene revealed an unmethylated DNA promoter, similar to that detected in normal brain tissues. However, a differential histone code with distinct euchromatin marks—AcH3, AcH4, and H3k4me2—was specifically detected in tumors, unlike in normal brain tissues, which were found predominantly enriched with heterochromatin marks such as H3K9me2 and H3K27me3. In contrast, a differential methylation pattern of DNMT3B gene promoter occurred in glioma tumors, wherein it was found hypomethylated. Transcriptional silencing by CpG island methylation is a prevalent mechanism for inactivation of TSGs. Inhibiting DNMTs by 5-azacytidine (DNMT inhibitor) treatment led to significant inhibition of expression of DNMT1 and DNMT3B and enhanced expression of TSGs such as PTEN and p21 analyzed in this study. Our studies have identified effects of increased presence of DNMTs on inhibition of tumor suppressors that are epigenetically silenced in gliomas, thereby leading to aberrant regulation of cell cycle progression and failure to maintain genomic stability.
         datePublished:2011-01-13T00:00:00Z
         dateModified:2011-01-13T00:00:00Z
         pageStart:483
         pageEnd:494
         sameAs:https://doi.org/10.1007/s11060-010-0520-2
         keywords:
            Tumor suppressor genes
            Histone modifications
            Acetylation
            DNA methylation
            MS-PCR
            ChIP assay
            Oncology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig6_HTML.gif
         isPartOf:
            name:Journal of Neuro-Oncology
            issn:
               1573-7373
               0167-594X
            volumeNumber:104
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ganeshkumar Rajendran
               affiliation:
                     name:National Centre for Cell Science (NCCS)
                     address:
                        name:National Centre for Cell Science (NCCS), Pune, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karthik Shanmuganandam
               affiliation:
                     name:National Centre for Cell Science (NCCS)
                     address:
                        name:National Centre for Cell Science (NCCS), Pune, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ameya Bendre
               affiliation:
                     name:National Centre for Cell Science (NCCS)
                     address:
                        name:National Centre for Cell Science (NCCS), Pune, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dattatreya Mujumdar
               affiliation:
                     name:Seth GS Medical College and KEM Hospital
                     address:
                        name:Seth GS Medical College and KEM Hospital, Mumbai, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abhay Goel
               affiliation:
                     name:Seth GS Medical College and KEM Hospital
                     address:
                        name:Seth GS Medical College and KEM Hospital, Mumbai, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anjali Shiras
               affiliation:
                     name:National Centre for Cell Science (NCCS)
                     address:
                        name:National Centre for Cell Science (NCCS), Pune, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas
      description:The role of epigenetics and significance of aberrant gene regulation in etiology of cancer is a well-established phenomenon. The hallmark of cancer epigenetics is aberrant DNA methylation consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes (TSGs) by DNA methyltransferases (DNMTs). In mammals, DNA methylation is catalyzed by DNMTs encoded by DNMT1, DNMT3A, and DNMT3B. Interestingly, little is known about variation in the methylation status of epigenetic regulators themselves in gliomas. Here, we report significant overexpression of DNMT1 and DNMT3B. A study of the methylation status and histone modifications at the promoter region of DNA methyltransferase I (DNMT1) gene revealed an unmethylated DNA promoter, similar to that detected in normal brain tissues. However, a differential histone code with distinct euchromatin marks—AcH3, AcH4, and H3k4me2—was specifically detected in tumors, unlike in normal brain tissues, which were found predominantly enriched with heterochromatin marks such as H3K9me2 and H3K27me3. In contrast, a differential methylation pattern of DNMT3B gene promoter occurred in glioma tumors, wherein it was found hypomethylated. Transcriptional silencing by CpG island methylation is a prevalent mechanism for inactivation of TSGs. Inhibiting DNMTs by 5-azacytidine (DNMT inhibitor) treatment led to significant inhibition of expression of DNMT1 and DNMT3B and enhanced expression of TSGs such as PTEN and p21 analyzed in this study. Our studies have identified effects of increased presence of DNMTs on inhibition of tumor suppressors that are epigenetically silenced in gliomas, thereby leading to aberrant regulation of cell cycle progression and failure to maintain genomic stability.
      datePublished:2011-01-13T00:00:00Z
      dateModified:2011-01-13T00:00:00Z
      pageStart:483
      pageEnd:494
      sameAs:https://doi.org/10.1007/s11060-010-0520-2
      keywords:
         Tumor suppressor genes
         Histone modifications
         Acetylation
         DNA methylation
         MS-PCR
         ChIP assay
         Oncology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0520-2/MediaObjects/11060_2010_520_Fig6_HTML.gif
      isPartOf:
         name:Journal of Neuro-Oncology
         issn:
            1573-7373
            0167-594X
         volumeNumber:104
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ganeshkumar Rajendran
            affiliation:
                  name:National Centre for Cell Science (NCCS)
                  address:
                     name:National Centre for Cell Science (NCCS), Pune, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karthik Shanmuganandam
            affiliation:
                  name:National Centre for Cell Science (NCCS)
                  address:
                     name:National Centre for Cell Science (NCCS), Pune, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ameya Bendre
            affiliation:
                  name:National Centre for Cell Science (NCCS)
                  address:
                     name:National Centre for Cell Science (NCCS), Pune, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dattatreya Mujumdar
            affiliation:
                  name:Seth GS Medical College and KEM Hospital
                  address:
                     name:Seth GS Medical College and KEM Hospital, Mumbai, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abhay Goel
            affiliation:
                  name:Seth GS Medical College and KEM Hospital
                  address:
                     name:Seth GS Medical College and KEM Hospital, Mumbai, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anjali Shiras
            affiliation:
                  name:National Centre for Cell Science (NCCS)
                  address:
                     name:National Centre for Cell Science (NCCS), Pune, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuro-Oncology
      issn:
         1573-7373
         0167-594X
      volumeNumber:104
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Centre for Cell Science (NCCS)
      address:
         name:National Centre for Cell Science (NCCS), Pune, India
         type:PostalAddress
      name:National Centre for Cell Science (NCCS)
      address:
         name:National Centre for Cell Science (NCCS), Pune, India
         type:PostalAddress
      name:National Centre for Cell Science (NCCS)
      address:
         name:National Centre for Cell Science (NCCS), Pune, India
         type:PostalAddress
      name:Seth GS Medical College and KEM Hospital
      address:
         name:Seth GS Medical College and KEM Hospital, Mumbai, India
         type:PostalAddress
      name:Seth GS Medical College and KEM Hospital
      address:
         name:Seth GS Medical College and KEM Hospital, Mumbai, India
         type:PostalAddress
      name:National Centre for Cell Science (NCCS)
      address:
         name:National Centre for Cell Science (NCCS), Pune, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ganeshkumar Rajendran
      affiliation:
            name:National Centre for Cell Science (NCCS)
            address:
               name:National Centre for Cell Science (NCCS), Pune, India
               type:PostalAddress
            type:Organization
      name:Karthik Shanmuganandam
      affiliation:
            name:National Centre for Cell Science (NCCS)
            address:
               name:National Centre for Cell Science (NCCS), Pune, India
               type:PostalAddress
            type:Organization
      name:Ameya Bendre
      affiliation:
            name:National Centre for Cell Science (NCCS)
            address:
               name:National Centre for Cell Science (NCCS), Pune, India
               type:PostalAddress
            type:Organization
      name:Dattatreya Mujumdar
      affiliation:
            name:Seth GS Medical College and KEM Hospital
            address:
               name:Seth GS Medical College and KEM Hospital, Mumbai, India
               type:PostalAddress
            type:Organization
      name:Abhay Goel
      affiliation:
            name:Seth GS Medical College and KEM Hospital
            address:
               name:Seth GS Medical College and KEM Hospital, Mumbai, India
               type:PostalAddress
            type:Organization
      name:Anjali Shiras
      affiliation:
            name:National Centre for Cell Science (NCCS)
            address:
               name:National Centre for Cell Science (NCCS), Pune, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:National Centre for Cell Science (NCCS), Pune, India
      name:National Centre for Cell Science (NCCS), Pune, India
      name:National Centre for Cell Science (NCCS), Pune, India
      name:Seth GS Medical College and KEM Hospital, Mumbai, India
      name:Seth GS Medical College and KEM Hospital, Mumbai, India
      name:National Centre for Cell Science (NCCS), Pune, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(223)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.44s.